Cardiff Oncology Inc
General ticker "CRDF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $151.3M
Cardiff Oncology Inc follows the US Stock Market performance with the rate: 10.2%.
Estimated limits based on current volatility of 11.9%: low 4.01$, high 4.74$
Factors to consider:
- Current price 53.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.85$, 2.55$]
- 2024-12-30 to 2025-12-30 estimated range: [1.08$, 2.98$]
Financial Metrics affecting the CRDF estimates:
- Negative: Non-GAAP EPS, $ of -0.93 <= 0.10
- Negative: Operating profit margin, % of -98.94 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -34.19 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
Short-term CRDF quotes
Long-term CRDF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.36MM | $0.39MM | $0.49MM |
| Operating Expenses | $29.21MM | $40.29MM | $45.90MM |
| Operating Income | $-28.86MM | $-39.90MM | $-45.41MM |
| Non-Operating Income | $0.56MM | $1.20MM | $3.97MM |
| Interest Expense | $0.00MM | $1.58MM | $0.00MM |
| R&D Expense | $17.38MM | $27.11MM | $32.86MM |
| Income(Loss) | $-28.29MM | $-38.70MM | $-41.44MM |
| Profit(Loss) | $-28.29MM | $-38.70MM | $-41.44MM |
| Stockholders Equity | $140.42MM | $106.34MM | $69.74MM |
| Assets | $149.54MM | $116.19MM | $81.64MM |
| Operating Cash Flow | $-23.04MM | $-33.82MM | $-30.89MM |
| Capital expenditure | $0.20MM | $0.89MM | $0.58MM |
| Investing Cash Flow | $-131.45MM | $38.15MM | $36.20MM |
| Financing Cash Flow | $35.45MM | $0.07MM | $0.00MM |
| Earnings Per Share* | $-0.71 | $-0.86 | $-0.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.